Optimeos Life Sciences, Inc.

CIK 1819114 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Optimeos Life Sciences, Inc..

Recent SEC filings

FiledFormAccession number
Jun 3, 2026D0001819114-26-000001
Nov 26, 2024D/A0001819114-24-000001
Jul 7, 2023D0001819114-23-000001
Jun 1, 2021D0001819114-21-000001
Aug 7, 2020D0001819114-20-000001